Chemoinformaics analysis of BETA-N-OXALO-L-ALPHA-BETA-DIAMINOPROPIONIC-ACID
| Molecular Weight | 176.128 | nRot | 3 |
| Heavy Atom Molecular Weight | 168.064 | nRig | 3 |
| Exact Molecular Weight | 176.043 | nRing | 0 |
| Solubility: LogS | -1.248 | nHRing | 0 |
| Solubility: LogP | -3.59 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 19.8943 |
| nHD | 4 | BPOL | 10.6297 |
| QED | 0.354 |
| Synth | 2.746 |
| Natural Product Likeliness | 0.666 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.475 |
| HIA | 0.016 |
| CACO-2 | -6.477 |
| MDCK | 0.00336188 |
| BBB | 0.221 |
| PPB | 0.0968753 |
| VDSS | 0.332 |
| FU | 0.813305 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.01 |
| CYP2c19-inh | 0.09 |
| CYP2c19-sub | 0.033 |
| CYP2c9-inh | 0.174 |
| CYP2c9-sub | 0.217 |
| CYP2d6-inh | 0.019 |
| CYP2d6-sub | 0.131 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.003 |
| CL | 3.561 |
| T12 | 0.721 |
| hERG | 0.021 |
| Ames | 0.036 |
| ROA | 0.007 |
| SkinSen | 0.218 |
| Carcinogencity | 0.014 |
| EI | 0.112 |
| Respiratory | 0.13 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.866295 |